_version_ 1811275025039228928
author Patrick Badertscher
Thomas Nestelberger
Jeanne du Fay de Lavallaz
Martin Than
Beata Morawiec
Damian Kawecki
Òscar Miró
Beatriz López
F. Javier Martin‐Sanchez
José Bustamante
Nicolas Geigy
Michael Christ
Salvatore Di Somma
W. Frank Peacock
Louise Cullen
François Sarasin
Dayana Flores
Michael Tschuck
Jasper Boeddinghaus
Raphael Twerenbold
Karin Wildi
Zaid Sabti
Christian Puelacher
Maria Rubini Giménez
Nikola Kozhuharov
Samyut Shrestha
Ivo Strebel
Katharina Rentsch
Dagmar I. Keller
Imke Poepping
Andreas Buser
Wanda Kloos
Jens Lohrmann
Michael Kuehne
Stefan Osswald
Tobias Reichlin
Christian Mueller
author_facet Patrick Badertscher
Thomas Nestelberger
Jeanne du Fay de Lavallaz
Martin Than
Beata Morawiec
Damian Kawecki
Òscar Miró
Beatriz López
F. Javier Martin‐Sanchez
José Bustamante
Nicolas Geigy
Michael Christ
Salvatore Di Somma
W. Frank Peacock
Louise Cullen
François Sarasin
Dayana Flores
Michael Tschuck
Jasper Boeddinghaus
Raphael Twerenbold
Karin Wildi
Zaid Sabti
Christian Puelacher
Maria Rubini Giménez
Nikola Kozhuharov
Samyut Shrestha
Ivo Strebel
Katharina Rentsch
Dagmar I. Keller
Imke Poepping
Andreas Buser
Wanda Kloos
Jens Lohrmann
Michael Kuehne
Stefan Osswald
Tobias Reichlin
Christian Mueller
author_sort Patrick Badertscher
collection DOAJ
description BackgroundThe early detection of cardiac syncope is challenging. We aimed to evaluate the diagnostic value of 4 novel prohormones, quantifying different neurohumoral pathways, possibly involved in the pathophysiological features of cardiac syncope: midregional–pro‐A‐type natriuretic peptide (MRproANP), C‐terminal proendothelin 1, copeptin, and midregional‐proadrenomedullin. Methods and ResultsWe prospectively enrolled unselected patients presenting with syncope to the emergency department (ED) in a diagnostic multicenter study. ED probability of cardiac syncope was quantified by the treating ED physician using a visual analogue scale. Prohormones were measured in a blinded manner. Two independent cardiologists adjudicated the final diagnosis on the basis of all clinical information, including 1‐year follow‐up. Among 689 patients, cardiac syncope was the adjudicated final diagnosis in 125 (18%). Plasma concentrations of MRproANP, C‐terminal proendothelin 1, copeptin, and midregional‐proadrenomedullin were all significantly higher in patients with cardiac syncope compared with patients with other causes (P<0.001). The diagnostic accuracies for cardiac syncope, as quantified by the area under the curve, were 0.80 (95% confidence interval [CI], 0.76–0.84), 0.69 (95% CI, 0.64–0.74), 0.58 (95% CI, 0.52–0.63), and 0.68 (95% CI, 0.63–0.73), respectively. In conjunction with the ED probability (0.86; 95% CI, 0.82–0.90), MRproANP, but not the other prohormone, improved the area under the curve to 0.90 (95% CI, 0.87–0.93), which was significantly higher than for the ED probability alone (P=0.003). An algorithm to rule out cardiac syncope combining an MRproANP level of <77 pmol/L and an ED probability of <20% had a sensitivity and a negative predictive value of 99%. ConclusionsThe use of MRproANP significantly improves the early detection of cardiac syncope among unselected patients presenting to the ED with syncope. Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01548352.
first_indexed 2024-04-12T23:30:41Z
format Article
id doaj.art-ac4691f74ef8486489e525be2f4d17c0
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-12T23:30:41Z
publishDate 2017-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-ac4691f74ef8486489e525be2f4d17c02022-12-22T03:12:18ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802017-12-0161210.1161/JAHA.117.006592Prohormones in the Early Diagnosis of Cardiac SyncopePatrick Badertscher0Thomas Nestelberger1Jeanne du Fay de Lavallaz2Martin Than3Beata Morawiec4Damian Kawecki5Òscar Miró6Beatriz López7F. Javier Martin‐Sanchez8José Bustamante9Nicolas Geigy10Michael Christ11Salvatore Di Somma12W. Frank Peacock13Louise Cullen14François Sarasin15Dayana Flores16Michael Tschuck17Jasper Boeddinghaus18Raphael Twerenbold19Karin Wildi20Zaid Sabti21Christian Puelacher22Maria Rubini Giménez23Nikola Kozhuharov24Samyut Shrestha25Ivo Strebel26Katharina Rentsch27Dagmar I. Keller28Imke Poepping29Andreas Buser30Wanda Kloos31Jens Lohrmann32Michael Kuehne33Stefan Osswald34Tobias Reichlin35Christian Mueller36Cardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyDepartment of Emergency Medicine, Hospital of Liestal, SwitzerlandGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyGREAT Network, Rome, ItalyEmergency Department, Hôpitaux Universitaires de Genève, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandLaboratory Medicine, University Hospital Basel University of Basel, SwitzerlandEmergency Department, University Hospital Zurich, Zurich, SwitzerlandDepartment of Internal Medicine, Hospital of Lachen, SwitzerlandDepartment of Hematology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandCardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel University of Basel, SwitzerlandBackgroundThe early detection of cardiac syncope is challenging. We aimed to evaluate the diagnostic value of 4 novel prohormones, quantifying different neurohumoral pathways, possibly involved in the pathophysiological features of cardiac syncope: midregional–pro‐A‐type natriuretic peptide (MRproANP), C‐terminal proendothelin 1, copeptin, and midregional‐proadrenomedullin. Methods and ResultsWe prospectively enrolled unselected patients presenting with syncope to the emergency department (ED) in a diagnostic multicenter study. ED probability of cardiac syncope was quantified by the treating ED physician using a visual analogue scale. Prohormones were measured in a blinded manner. Two independent cardiologists adjudicated the final diagnosis on the basis of all clinical information, including 1‐year follow‐up. Among 689 patients, cardiac syncope was the adjudicated final diagnosis in 125 (18%). Plasma concentrations of MRproANP, C‐terminal proendothelin 1, copeptin, and midregional‐proadrenomedullin were all significantly higher in patients with cardiac syncope compared with patients with other causes (P<0.001). The diagnostic accuracies for cardiac syncope, as quantified by the area under the curve, were 0.80 (95% confidence interval [CI], 0.76–0.84), 0.69 (95% CI, 0.64–0.74), 0.58 (95% CI, 0.52–0.63), and 0.68 (95% CI, 0.63–0.73), respectively. In conjunction with the ED probability (0.86; 95% CI, 0.82–0.90), MRproANP, but not the other prohormone, improved the area under the curve to 0.90 (95% CI, 0.87–0.93), which was significantly higher than for the ED probability alone (P=0.003). An algorithm to rule out cardiac syncope combining an MRproANP level of <77 pmol/L and an ED probability of <20% had a sensitivity and a negative predictive value of 99%. ConclusionsThe use of MRproANP significantly improves the early detection of cardiac syncope among unselected patients presenting to the ED with syncope. Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01548352.https://www.ahajournals.org/doi/10.1161/JAHA.117.006592arrhythmiabiomarkerdiagnosissyncope (fainting)
spellingShingle Patrick Badertscher
Thomas Nestelberger
Jeanne du Fay de Lavallaz
Martin Than
Beata Morawiec
Damian Kawecki
Òscar Miró
Beatriz López
F. Javier Martin‐Sanchez
José Bustamante
Nicolas Geigy
Michael Christ
Salvatore Di Somma
W. Frank Peacock
Louise Cullen
François Sarasin
Dayana Flores
Michael Tschuck
Jasper Boeddinghaus
Raphael Twerenbold
Karin Wildi
Zaid Sabti
Christian Puelacher
Maria Rubini Giménez
Nikola Kozhuharov
Samyut Shrestha
Ivo Strebel
Katharina Rentsch
Dagmar I. Keller
Imke Poepping
Andreas Buser
Wanda Kloos
Jens Lohrmann
Michael Kuehne
Stefan Osswald
Tobias Reichlin
Christian Mueller
Prohormones in the Early Diagnosis of Cardiac Syncope
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
arrhythmia
biomarker
diagnosis
syncope (fainting)
title Prohormones in the Early Diagnosis of Cardiac Syncope
title_full Prohormones in the Early Diagnosis of Cardiac Syncope
title_fullStr Prohormones in the Early Diagnosis of Cardiac Syncope
title_full_unstemmed Prohormones in the Early Diagnosis of Cardiac Syncope
title_short Prohormones in the Early Diagnosis of Cardiac Syncope
title_sort prohormones in the early diagnosis of cardiac syncope
topic arrhythmia
biomarker
diagnosis
syncope (fainting)
url https://www.ahajournals.org/doi/10.1161/JAHA.117.006592
work_keys_str_mv AT patrickbadertscher prohormonesintheearlydiagnosisofcardiacsyncope
AT thomasnestelberger prohormonesintheearlydiagnosisofcardiacsyncope
AT jeannedufaydelavallaz prohormonesintheearlydiagnosisofcardiacsyncope
AT martinthan prohormonesintheearlydiagnosisofcardiacsyncope
AT beatamorawiec prohormonesintheearlydiagnosisofcardiacsyncope
AT damiankawecki prohormonesintheearlydiagnosisofcardiacsyncope
AT oscarmiro prohormonesintheearlydiagnosisofcardiacsyncope
AT beatrizlopez prohormonesintheearlydiagnosisofcardiacsyncope
AT fjaviermartinsanchez prohormonesintheearlydiagnosisofcardiacsyncope
AT josebustamante prohormonesintheearlydiagnosisofcardiacsyncope
AT nicolasgeigy prohormonesintheearlydiagnosisofcardiacsyncope
AT michaelchrist prohormonesintheearlydiagnosisofcardiacsyncope
AT salvatoredisomma prohormonesintheearlydiagnosisofcardiacsyncope
AT wfrankpeacock prohormonesintheearlydiagnosisofcardiacsyncope
AT louisecullen prohormonesintheearlydiagnosisofcardiacsyncope
AT francoissarasin prohormonesintheearlydiagnosisofcardiacsyncope
AT dayanaflores prohormonesintheearlydiagnosisofcardiacsyncope
AT michaeltschuck prohormonesintheearlydiagnosisofcardiacsyncope
AT jasperboeddinghaus prohormonesintheearlydiagnosisofcardiacsyncope
AT raphaeltwerenbold prohormonesintheearlydiagnosisofcardiacsyncope
AT karinwildi prohormonesintheearlydiagnosisofcardiacsyncope
AT zaidsabti prohormonesintheearlydiagnosisofcardiacsyncope
AT christianpuelacher prohormonesintheearlydiagnosisofcardiacsyncope
AT mariarubinigimenez prohormonesintheearlydiagnosisofcardiacsyncope
AT nikolakozhuharov prohormonesintheearlydiagnosisofcardiacsyncope
AT samyutshrestha prohormonesintheearlydiagnosisofcardiacsyncope
AT ivostrebel prohormonesintheearlydiagnosisofcardiacsyncope
AT katharinarentsch prohormonesintheearlydiagnosisofcardiacsyncope
AT dagmarikeller prohormonesintheearlydiagnosisofcardiacsyncope
AT imkepoepping prohormonesintheearlydiagnosisofcardiacsyncope
AT andreasbuser prohormonesintheearlydiagnosisofcardiacsyncope
AT wandakloos prohormonesintheearlydiagnosisofcardiacsyncope
AT jenslohrmann prohormonesintheearlydiagnosisofcardiacsyncope
AT michaelkuehne prohormonesintheearlydiagnosisofcardiacsyncope
AT stefanosswald prohormonesintheearlydiagnosisofcardiacsyncope
AT tobiasreichlin prohormonesintheearlydiagnosisofcardiacsyncope
AT christianmueller prohormonesintheearlydiagnosisofcardiacsyncope